Lavipharm S.A. (ATH:LAVI)

Lavipharm Revenue

Lavipharm had revenue of 19.79M EUR in the quarter ending June 30, 2026, with 41.27% growth. This brings the company's total for the last twelve months to 70.32M, up 28.65% year-over-year. In the year 2025, Lavipharm had annual revenue of 62.58M with 18.20% growth. That makes Lavipharm the 24,535th largest company in the world by revenue and 67th in Greece.

• Revenue (ttm): 70.32M
• Revenue Growth: +28.65%
• P/S Ratio: 3.64
• Revenue / Employee: 229.79K
• Employees: 306
• Market Cap: 254.12M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Greece 38.81M 62.0%
• European Union 17.62M 28.2%
• Other countries 6.15M 9.8%

Fiscal year ended Dec 31, 2025 See the full Lavipharm breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.58M	9.64M	18.20%
Dec 31, 2024	52.95M	5.11M	10.68%
Dec 31, 2023	47.84M	8.78M	22.48%
Dec 31, 2022	39.06M	-667.00K	-1.68%
Dec 31, 2021	39.72M	2.09M	5.54%

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error